NIFTY
129.20  1.29%
 10108.30
S&P BSE SENSEX
527.87  1.56%
 34353.4
Arihant Multi Commercial Ltd.
NSE : NA BSE : 506113 ISIN code : INE776N01028
on 03-Jun-2020 09:07
NSE
  
Rs.
 
Days Low
Rs. 134.4
Days High
Rs. 134.4

Open Rs. 134.4
 
52 week Low
Rs. 134.4
52 week High
Rs.134.4
 
 
Bid :                 0.00 (0)
Offer :        134.40 (66601)
BSE
Rs.134.40
0    0%
on 27-Aug-2015
BSE
0    0%
Rs. 134.40
 
Days Low
Rs.
Days High
Rs.

Open Rs. 
 
52 week Low
Rs.
52 week High
Rs.
 
 
Bid :                 0.00 (0)
Offer :        134.40 (66601)
NSE
Rs.
  
 
 
Last Price (Rs.)  134.40 Value  238425.00
Net Change (Rs.)  0.00 Best Buy  0.00
Volume  1774 Best Sell  134.40
Prev.Close (Rs.)  134.40 Best Quantity  0
Open (Rs.)  134.40 Sell Quantity  66601
High (Rs.)  134.40 52-Week High (Rs.)  134.40
Low (Rs.)  134.40 52-Week Low (Rs.)  134.40
Face Value (Rs.)  1 Market Cap.(Rs/ Mn)  4870.66
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital36.24 36.24 36.24 
Share Capital36.24 36.24 36.24 
Share Capital36.24 36.24 36.24 
Share Capital36.24 36.24 36.24 
Share Capital36.24 36.24 36.24 
Currents Investments0.00 0.00 0.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
ICICI Securities 389.35 125427 36.98 25.76 2.83
Multi Commodity Exch 1298.20 66206 303.53 48.50 1.54
Indiabulls Ventures 75.30 46317 96.33 40.52 1.33
Dolat Investment 43.70 7691 11.25 15.21 0.23
Geojit Finl. Service 20.55 4897 16.85 16.70 4.87
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Mar 2018Dec 2017Sep 2017
Net Sales34.011.971.90
Operating Profit-4.941.531.22
PBDT-4.941.531.22
Net Profit-4.951.531.22
More> 
 
Company News
7/7/2018 12:00:00 AM
Arihant Multi Commercial informs about financial results
10/21/2016 12:00:00 AM
Lifeline Drugs & Pharma informs about board meeting
4/27/2016 12:00:00 AM
Lifeline Drugs & Pharma informs about board meeting
More>
 
Ratios
   Earnings Per Share (Rs)0.00 
   Book NAV/Share(Rs)5.96 
   PAT Margin (%)0.01 
   Asset Turnover(x)0.18 
   PER(x)0.00 
   Yield(%)NA 
   EV/Core EBITDA(x)904.13 
   M Cap / Sales0.00 
   Net Sales Growth(%)19.15 
   PAT Growth(%)-88.41 
   Total Debt/Equity(x)0.00 
   Current Ratio(x)15.28 
   Quick Ratio(x)9.21 
   Total Debt/Mcap(x)NA 
More>